Patient-controlled intravenous administration of dexmedetomidine with nalbuphine versus sufentanil for post cesarean delivery analgesia: A retrospective observational study
- PMID: 37092309
- PMCID: PMC11895903
- DOI: 10.1002/kjm2.12689
Patient-controlled intravenous administration of dexmedetomidine with nalbuphine versus sufentanil for post cesarean delivery analgesia: A retrospective observational study
Abstract
This retrospective observational study aims to investigate the patient-controlled intravenous analgesia (PCIA) of dexmedetomidine (DEX) with nalbuphine (NAL) versus sufentanil (SUF) for post-cesarean delivery management. A total of 300 women were evaluated who underwent cesarean section surgery with combined spinal-epidural anesthesia. After surgery, all patients were connected to a patient-controlled analgesia pump. The PCIA protocol was programmed with 0.11 μg/kg/h DEX in combination with 0.03 μg/kg/h SUF in Group I (n = 150) or 0.11 μg/kg/h DEX in combination with 0.03 mg/kg/h NAL in Group II (n = 150). There was no significant difference in incision pain and sedation level between the two groups within 48 h after the surgery assessed by visual analog scale (VAS) and Ramsay sedation scale, respectively. However, at 2, 6, 12, and 24 h after surgery, visceral pain at rest and at mobilization was alleviated in the Group II as compared with the Group I with lower VAS scores. Moreover, fewer adverse reactions were found in the Group II when compared with Group I, including postpartum respiratory depression, nausea/vomiting, urinary retention, and cardiovascular events. Overall, there was an increased patient satisfaction in the Group II as compared with the Group I. Based on the results of this study, it seems that adding NAL to PCIA with DEX, as compared to SUF with DEX, have an effect on reducing the intensity of visceral pain after cesarean section with less adverse reactions and higher patient satisfaction.
Keywords: cesarean delivery; dexmedetomidine; nalbuphine; patient-controlled intravenous analgesia; sufentanil.
© 2023 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
The optimal dose of dexmedetomidine added to an sufentanil-based analgesic regimen for postoperative pain control in spine surgery: A probit analysis study.Medicine (Baltimore). 2016 Sep;95(39):e4776. doi: 10.1097/MD.0000000000004776. Medicine (Baltimore). 2016. PMID: 27684802 Free PMC article. Clinical Trial.
-
Effects of Adding Transversus Abdominis Plane Block on Intravenous Nalbuphine and Dexmedetomidine for Severely Pre-Eclamptic Parturients After Cesarean Delivery.Kaohsiung J Med Sci. 2025 Jul;41(7):e70027. doi: 10.1002/kjm2.70027. Epub 2025 May 21. Kaohsiung J Med Sci. 2025. PMID: 40396634 Free PMC article. Clinical Trial.
-
Dexmedetomidine Added to Sufentanil Patient-Controlled Intravenous Analgesia Relieves the Postoperative Pain after Cesarean Delivery: A Prospective Randomized Controlled Multicenter Study.Sci Rep. 2018 Jul 2;8(1):9952. doi: 10.1038/s41598-018-27619-3. Sci Rep. 2018. PMID: 29967332 Free PMC article. Clinical Trial.
-
Efficacy and safety of dexmedetomidine combined with tramadol for patient-controlled intravenous analgesia in Chinese surgical patients: A systematic review and meta-analysis.Medicine (Baltimore). 2020 Jan;99(3):e18825. doi: 10.1097/MD.0000000000018825. Medicine (Baltimore). 2020. PMID: 32011494 Free PMC article.
-
Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis.Front Pharmacol. 2024 Feb 7;15:1247646. doi: 10.3389/fphar.2024.1247646. eCollection 2024. Front Pharmacol. 2024. PMID: 38384296 Free PMC article. Review.
Cited by
-
Impact of esketamine intravenous analgesic pump on pain and depression post-cesarean.BMC Surg. 2025 Apr 8;25(1):144. doi: 10.1186/s12893-025-02868-y. BMC Surg. 2025. PMID: 40200243 Free PMC article.
-
Comparison of intravenous nalbuphine and sufentanil on the median effective effect-site concentration of propofol to attenuate the response to cervical dilation during hysteroscopy: a double-blind, dose-response study.BMC Anesthesiol. 2025 Jul 7;25(1):342. doi: 10.1186/s12871-025-03208-6. BMC Anesthesiol. 2025. PMID: 40624484 Free PMC article. Clinical Trial.
-
A single epidural administration of butorphanol combined with patient-controlled intravenous analgesia relieves postpartum contraction pain after cesarean section: A randomized clinical trial.Medicine (Baltimore). 2024 Dec 27;103(52):e40887. doi: 10.1097/MD.0000000000040887. Medicine (Baltimore). 2024. PMID: 39969329 Free PMC article. Clinical Trial.
References
-
- Antoine C, Young BK. Cesarean section one hundred years 1920–2020: the good, the bad and the ugly. J Perinat Med. 2020;49(1):5–16. - PubMed
-
- Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013;118(4):934–44. - PubMed
-
- Koyyalamudi V, Sidhu G, Cornett EM, Nguyen V, Labrie‐Brown C, Fox CJ, et al. New labor pain treatment options. Curr Pain Headache Rep. 2016;20(2):11. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical